Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing
MELBOURNE, Australia, Oct. 16, 2024 /PRNewswire/ -- Members Health is calling for major reforms to boost health care accessibility and affordability and improve transparency of hospitals and doctors across Australia as part of a landmark report released today for the not-for-profit health insurance sector. The 'Economic and Social Impact of the Members...
Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge
SYDNEY, Oct. 16, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the $525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The award recognizes Cardiex's innovative solutions for improving maternal health...
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
MELBOURNE, Australia, Oct. 16, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust Limited, to Neurizon Therapeutics Limited. The name change was approved by shareholders at the Company's...
MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members
American Heart Association Ventures invests in MDisrupt Lisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins the MDisrupt board MDisrupt's marketplace will be made available to thousands of the American Heart Association's professional members The American Heart Association and MDisrupt collaborate to expand the AI-Powered Health...
RLDatix Appoints Dan Michelson as Chief Executive Officer
Michelson succeeds Jeff Surges who transitions into Board Advisor Role CHICAGO, Oct. 16, 2024 /PRNewswire/ -- RLDatix, a leading global provider of connected healthcare operations software and services, announced today the appointment of Dan Michelson as its new Chief Executive Officer and a member of the Board, effective November 1, 2024. Michelson succeeds Jeff Surges, who has led the...
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting
SHENZHEN, China, Oct. 15, 2024 /PRNewswire/ -- On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The abstract of the Phase II clinical study (CGZ203 trial) on the treatment of non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (MASH)...
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
The Groundbreaking Accure Laser System is now indicated for the long-term treatment of mild to severe inflammatory acne vulgaris BOULDER, Colo., Oct. 15, 2024 /PRNewswire/ -- Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that it has received a new...
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation
MILAN, Oct. 15, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, unveiled its Hyatrue® Sterile Sodium Hyaluronate (HA) and showcased its BloomseaN™ Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) at CPHI Milan. Known to be at "the heart of pharma", CPHI Milan as a global exhibition provides a platform for exchanging and showcasing advanced pharmaceutical...
Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’
- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical trial data analysis expertise SEOUL, South Korea, Oct. 15, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain...
Operation Smile Featured in “Beyond the Code,” a New Branded Series that Explores How AI Is Driving Transformative Change
VIRGINIA BEACH, Va., Oct. 15, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its involvement in Beyond the Code, a new branded series presented by Partnership on AI (PAI) and produced by BBC StoryWorks Commercial Productions. The first of its kind, this online series – which includes a story produced for Operation Smile of how AI is improving...
